Pediatric Hematology/Oncology

Nationwide Children

Questions discussed in this category

Is there any scenario where you would consider treating a relapsed AYA patient with Hodgkin Lymphoma without consolidative auto transplant?

If so, what treatment regimen would you recommend?

1 Answer available

What is the preferred regimen for AYA patients with T-Cell Lymphoblastic Lymphoma?

1 Answer available

Papers discussed in this category

Journal of the National Comprehensive Cancer Network : JNCCN, 2012-05

Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002-09-15

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Cancer, 2010-09-15

Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients.

Pediatric blood & cancer, 2006-03

APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial.

Pediatric blood & cancer, 2014-04

Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-03-20

Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001-05-01

Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912.

Annals of oncology : official journal of the European Society for Medical Oncology, 2011-02

Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.

Pediatric blood & cancer, 2015-01

Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report.

The Lancet. Oncology, 2018-09

Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.

N Engl J Med, 2022 Nov 03

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.

Lancet, 1993 Apr 24

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.

Lancet, 2002 Jun 15

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Crit Rev Oncol Hematol, 2014 May 02

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed or refractory Hodgkin lymphoma: a systematic review with meta-analysis.

Br J Haematol, 2014 Feb 07

Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.

Blood, 2023 Apr 27

Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.

J Clin Oncol, 2005 Sep 01

Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.

J Pediatr Hematol Oncol, 2004 Nov

Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease.

Hemasphere, 2020 Jan 10

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group.

J Pediatr Hematol Oncol, 2001 Jan

Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Br J Cancer, 1992 Dec

Outcome of children with resistant and relapsed Hodgkin's disease.

Int J Radiat Oncol Biol Phys, 2001 Dec 01

Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial.

J Clin Oncol, 2007 Apr 09

Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.

Pediatric Hematology/Oncology

Nationwide Children

Questions discussed in this category

Papers discussed in this category

Related Topics in Pediatric Hematology/Oncology